Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBT: 2015-2024

Historic EBT for Evolus (EOLS) over the last 10 years, with Dec 2024 value amounting to -$49.8 million.

  • Evolus' EBT rose 18.21% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.8 million, marking a year-over-year decrease of 4.90%. This contributed to the annual value of -$49.8 million for FY2024, which is 19.11% up from last year.
  • Evolus' EBT amounted to -$49.8 million in FY2024, which was up 19.11% from -$61.5 million recorded in FY2023.
  • In the past 5 years, Evolus' EBT ranged from a high of -$46.8 million in FY2021 and a low of -$162.9 million during FY2020.
  • In the last 3 years, Evolus' EBT had a median value of -$61.5 million in 2023 and averaged -$61.9 million.
  • In the last 5 years, Evolus' EBT soared by 71.30% in 2021 and then plummeted by 58.91% in 2022.
  • Evolus' EBT (Yearly) stood at -$162.9 million in 2020, then skyrocketed by 71.30% to -$46.8 million in 2021, then slumped by 58.91% to -$74.3 million in 2022, then increased by 17.23% to -$61.5 million in 2023, then rose by 19.11% to -$49.8 million in 2024.